AbbVie (ABBV) Change in Cash (2012 - 2026)

AbbVie has disclosed Change in Cash across 15 years of filings, most recently posting $4.2 billion for Q1 2026.

• In Q1 2026, Change in Cash rose 1292.55% year-over-year to $4.2 billion; the TTM figure through Mar 2026 stood at $4.2 billion (up 132.7% YoY), while the FY2025 annual figure was -$295.0 million, up 95.95% from the prior year.
• Change in Cash improved to $4.2 billion in Q1 2026, from -$400.0 million in the prior quarter.
• Over the last five years, Change in Cash for ABBV reached as high as $5.3 billion in Q1 2024 and fell as low as -$5.9 billion in Q3 2024.
• The 5-year median for Change in Cash is -$400.0 million (2025), against an average of -$20.9 million.
• Annual changes were most pronounced in 2022 — Change in Cash tumbled 379.33% — and 2026, when it soared 1292.55%.
• A 5-year view of Change in Cash shows it stood at -$2.6 billion in 2022, then jumped by 82.02% to -$473.0 million in 2023, then plunged by 266.38% to -$1.7 billion in 2024, then soared by 76.92% to -$400.0 million in 2025, then soared by 1140.5% to $4.2 billion in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $4.2 billion, -$400.0 million, and -$838.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.